#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic lymphocytic leukaemia refractory Undifferentiated sarcoma Vitamin B12 deficiency Idiopathic pulmonary fibrosis Uveal melanoma Myeloproliferative neoplasm Sexually transmitted disease Gastric cancer Lymphoma Primary biliary cholangitis Ornithine transcarbamoylase deficiency Choroid melanoma Pulmonary arterial hypertension Oesophageal adenocarcinoma stage III Bulbospinal muscular atrophy congenital More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage IV – Life with Disease Paraneoplastic neurological syndrome – Life with Disease Lysosomal storage disorder – Basic Information Mantle cell lymphoma – Trials in Disease Marfan’s syndrome – Life with Disease Haemolytic uraemic syndrome – Life with Disease Haemophilia – Treatment Leiomyosarcoma – Trials in Disease Rett syndrome – Trials in Disease Shprintzen-Goldberg syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    L-PROLINE Ngm707 Allopurinol Pyrazinamide Chlorphenamine Io102 Hydrochloride Digoxin Immune Fab (Ovine) Enalapril Maleate Erenumab Rbl012.2 Amlodipine E.coli Polysaccharide Avelumab Mesna Insulin Human (Rdna) Imlifidase Codeine Phosphate Ascorbic Acid Candesartan Amylase More therapies…

    Learn about Your Condition

    Stress Cardiac amyloidosis Bone marrow failure Malignant melanoma of eyelid Pneumococcal infection Cerebral haemorrhage Mucopolysaccharidosis III Meningioma malignant Multiple sclerosis relapse Thyroid disorder Pertussis Cachexia Neonatal respiratory failure Congenital ureteric anomaly Oesophagogastroscopy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Dasatinib and Quercetin or Nicotinamide Riboside for Patients with Osteoporosis or Osteopenia

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteopenia
    • Osteoporosis
    Investigated Drugs:
    • Dasatinib
    Denmark

  • Study on Human Serum Albumin and Sodium Chloride for Patients with Liver Cirrhosis and Ascites

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Human Serum Albumin
    • Sodium Chloride
    Belgium Denmark Germany Hungary The Netherlands Spain

  • Study on the Safety and Effects of Hydroxypropylbetadex Infusions in Patients with Early Alzheimer’s Disease

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Hydroxypropylbetadex
    Austria Germany

  • Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using CPX-351, Gemtuzumab Ozogamicin, and a Drug Combination

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Gemtuzumab Ozogamicin
    • Daunorubicin
    • Mitoxantrone Hydrochloride
    Austria Czechia Germany Greece Italy Poland

  • Study on the Effectiveness of Ropivacaine Hydrochloride, Anhydrous Lidocaine Hydrochloride, and Alfentanil for Patients Undergoing Minor Breast Cancer Surgery

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Anhydrous Lidocaine Hydrochloride
    • Ropivacaine Hydrochloride
    Denmark

  • Study on the Effects of Dirocaftor, Posenacaftor, and Nesolicaftor for Adults with Cystic Fibrosis

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Cystic fibrosis
    Investigated Drugs:
    • Dirocaftor
    • Nesolicaftor
    • Posenacaftor
    Belgium Czechia Denmark Germany Italy The Netherlands +3
Previous Page
1 … 888 889 890 891 892 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!